Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose ketamine for reducing opioid use in adult trauma patients
2020-004812-81Phase 3Active
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Physical trauma comparing Low-dose ketamine infusion with Placebo infusion (2 arms). Primary endpoint: Total opioid dose at 48 hours. Started Nov 2020; status: active.
02
Drugs
ketamine
03
Conditions
Physical trauma
Beyond the preview
Go deeper on 2020-004812-81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004812-81.